ATRA
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 42 patients (estimated)
- Sponsors
- Houston Methodist Hospital Research Institute, Houston Methodist Hospital Research Institute
- Collaborators
- Cancer Prevention Research Institute of Texas
- Tags
- Vitamins
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1975
- NCT Identifier
- NCT06536413
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.